Sort
25,944 grants matching “neurodegeneration”
Develop an ANS-based Personalized Cognitive Training for Mild Cognitive Impairment
$746,142Feng Vankee Lin · Stanford University · R33 · FY2025 · AG
Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies
$746,084Kurt R. Brunden · University Of Pennsylvania · U01 · FY2022 · AG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$746,016Elizabeth Head · University Of Kentucky · R01 · FY2018 · AG
Systems Biology of Humanized models of AD and genetic suppression in Drosophila
$745,880Robert A. Reenan · Brown University · R56 · FY2017 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2018 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2019 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,812Jane E Joseph · Medical University Of South Carolina · R01 · FY2020 · AG
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
$745,652Pamela J Lein · University Of California At Davis · R01 · FY2025 · AG
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
$745,651Robert G Kalb · Northwestern University At Chicago · R01 · FY2023 · NS
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults
$745,511Giovanni Schifitto · University Of Rochester · R01 · FY2022 · AG
Sex-Specific Genetic Drivers of Alzheimer's Disease Endophenotypes
$745,408Logan C Dumitrescu · Vanderbilt University Medical Center · R01 · FY2025 · AG
Using connectomics to characterize risk for Alzheimer's Disease
$745,391Jane E Joseph · Medical University Of South Carolina · R01 · FY2017 · AG
DYRK1A Inhibition as a Novel Treatment Approach for Alzheimer's Disease
$744,799Christopher Hulme · University Of Arizona · R01 · FY2023 · AG
Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training in MCI (The ACT Trial)
$744,622Fang Yu · University Of Minnesota · R01 · FY2019 · AG
Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life
$744,308Amy Lynn Byers · Northern California Institute/Res/Edu · R01 · FY2024 · AG
Defining modifiers and mechanisms of RAN translation
$744,302Joseph D Puglisi · Stanford University · R01 · FY2025 · AG
Novel pediatric anticonvulsants for nerve agents
$744,154Doodipala Samba Reddy · Texas A&M University Health Science Ctr · U01 · FY2022 · NS
Novel pathogenic mechanism of HIV-associated CNS neurological disorders
$744,154Michael Ilya Bukrinsky · George Washington University · R01 · FY2024 · NS
Cell Type and Circuit Mechanisms of Non-Invasive Brain Stimulation by Sensory Entrainment
$744,126Anton Arkhipov · Allen Institute · R01 · FY2025 · NS
Antisense Oligonucleotides for treating Spinocerebellar Ataxia Type 2
$743,700Stefan M. Pulst · University Of Utah · U01 · FY2020 · NS
Elucidating the biological differences between distinct fibrillar and non-fibrillar alpha-synuclein inclusions in human stem-cell models
$743,623Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2022 · NS
Models for aging and Alzheimer with image-based cerebrovascular network synthesis (iCNS)
$743,548Andreas A Linninger · University Of Illinois At Chicago · R56 · FY2020 · AG
Role of Neurotrophins in the Development of the Mammalian Nervous System
$743,429Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Core B: Clinical Core
$742,900Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · P30 · FY2025 · AG
The Epigenetics of Alzheimer's Disease
$742,500Li-Huei Tsai · Massachusetts Institute Of Technology · R01 · FY2014 · NS